Ninety-one AB MDPI-treated subjects (59%) achieved a 15% increase in FEV 1 within 30 minutes postdose on day 1 with a median time to onset of 5.4 minutes, and median duration of effect (15% increase) of @2 hours for one study and 3 hours for the other.